PTCT PTC Therapeutics Inc

PTC Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.

$38.56  -1.22 (-3.07%)
As of 01/27/2022 15:59:58 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/20/2013
Outstanding shares:  70,697,900
Average volume:  1,040,134
Market cap:   $2,767,822,785
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B17VCN9
Valuation   (See tab for details)
PE ratio:   -6.18
PB ratio:   26.79
PS ratio:   5.62
Return on equity:   -433.63%
Net income %:   -92.44%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy